Virbac SA manufactures and sells a range of products and services for companion and food-producing animals in France, Europe, Latin America, North America, the Asia Pacific, the Middle East, and Africa. The company offers a range of vaccines, dental hygiene, reproduction, dermatology, parasiticides, diagnostic, antibiotics, and aquaculture products; and veterinary medicines for anesthesia, geriatrics, behavior, and injectable micronutrients, as well as petfood and electronic identification. It serves veterinarians, farmers, and pet owners. Virbac SA was founded in 1968 and is headquartered in Carros, France.
P/E ratio for Virbac SA (VIRP.PA)
P/E ratio as of 2023: 24.58
According to Virbac SA's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 24.58. At the end of 2022 the company had a P/E ratio of 15.79.
P/E ratio history for Virbac SA from 2002 to 2023
PE ratio at the end of each year
| Year | P/E ratio |
|---|---|
| 2023 | 24.58 |
| 2022 | 15.79 |
| 2021 | 31.69 |
| 2020 | 14.76 |
| 2019 | 38.68 |
| 2018 | 47.69 |
| 2017 | -401.94 |
| 2016 | 40.68 |
| 2015 | 197.02 |
| 2014 | 23.10 |
| 2013 | 21.62 |
| 2012 | 18.94 |
| 2011 | 17.24 |
| 2010 | 17.52 |
| 2009 | 15.90 |
| 2008 | 13.75 |
| 2007 | 18.57 |
| 2006 | 16.33 |
| 2005 | 17.05 |
| 2004 | 12.97 |
| 2003 | 9.27 |
| 2002 | 6.18 |